| Prof Bernard Flynn |
| Monash University |
| Pulmonary hypertension |
| Therapeutic |
Key outcomes:
- Established a spin-off company Ankere Therapeutics
- $10,791,639 investment seed funding raised
| Prof Bernard Flynn |
| Monash University |
| Pulmonary hypertension |
| Therapeutic |
Key outcomes: